Loading the player… While vaccinations in the US and around the global community signal the potential to finally stabilize the COVID-19 pandemic, some experts are sharing concerns that not enough people are getting vaccinated, thereby jeopardizing the chances of the U.S. achieving herd immunity against the virus. The World Health Organization (WHO) describes herd immunity as… Read More »
More infectious COVID-19 variants are spreading in the U.S. at the same time as cases are falling and the national vaccination campaign is picking up steam. Put it all together, a Harvard epidemiologist said Friday, and it may all add up to a lucky break for us, and we may be spared a surge from… Read More »
New Regional Sales Executive and Solution Engineer will support Quortus U.S. expansion 2nd February 2021, California, US: Quortus Ltd, a leading provider of innovative private edge LTE and 5G network solutions, today announced the appointment of two new hires as the company expands its presence in the U.S. adding to its Mountain View, California base.… Read More »
With U.S. presidential and congressional campaigns in full swing, it’s not just Americans anxiously awaiting the results of the upcoming elections. The races could affect European pharma companies in a big way, and now ODDO BHF analysts are laying out potential ramifications for the industry there. Amid the intense campaigning by both parties, the “usual package of measures” on drug pricing and insurance has surfaced,… Read More »
AstraZeneca made waves last week when it signed a massive $ 750 million deal to ramp production of a University of Oxford COVID-19 vaccine up to 2 billion doses per year. Now, as part of a Trump administration effort to get shots into U.S. hands as soon as possible, AstraZeneca has agreed to another major… Read More »